Science Explorer Back to mapMap
Discussion
Researcher · Institut Paoli-Calmettes · France

Véronique Gelsi‐Boyer

Véronique Gelsi‐Boyer publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.

OpenAlex
World rank
#331,981
of 7,710,434 ranked researchers
Rank in France
#18,843
of 324,115
Works
73
Citations
5.5k
Citations per work
76.0
h-index
32
i10-index 45Top 10% in Hematology
Véronique Gelsi‐Boyer

What does Véronique Gelsi‐Boyer research?

Véronique Gelsi‐Boyer's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (19%).

Health Sciences: 50 works · 68.7% of their workMedicine: 50 works · 68.7% of their workHematology: 29 works · 40.1% of their workGenetics: 17 works · 22.9% of their workPublic Health, Environmental and Occupational Health: 2 works · 3.1% of their workRheumatology: 2 works · 2.6% of their workLife Sciences: 14 works · 19.3% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 19.3% of their workMolecular Biology: 11 works · 14.6% of their workGenetics: 3 works · 4.7% of their workEverything else: 9 works · 12.0% of their workTHEIR WORKVéroniqueGelsi‐Boyer73works
Life Sciences19%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5068.7%
    1. Biochemistry, Genetics and Molecular Biology1419.3%
  3. Everything else912.0%
  1. 1Hematology40% of their works
  2. 2Genetics23% of their works
  3. 3Molecular Biology15% of their works
  4. 4Genetics5% of their works
  5. 5Public Health, Environmental and Occupational Health3% of their works
  6. 6Rheumatology3% of their works

Research topics

Which keywords describe Véronique Gelsi‐Boyer's research?

The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, JAK2 Mutation, Myelofibrosis, BCR-ABL and Imatinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors683 topics
  2. Hematopoietic Stem Cells602 topics
  3. AML551 topic
  4. Acute Myeloid Leukemia551 topic
  5. JAK2 Mutation341 topic
  6. Myelofibrosis341 topic
  7. BCR-ABL181 topic
  8. Imatinib181 topic
  9. Chronic Lymphocytic Leukemia71 topic
  10. Genomic Aberrations71 topic
  11. Acute Lymphoblastic Leukemia61 topic
  12. Childhood Cancer61 topic
  13. DNA Methylation61 topic
  14. Histone Modification61 topic
  15. Genetic Mutations51 topic
  16. Neutropenia51 topic
  17. Acute Promyelocytic Leukemia41 topic
  18. Retinoic Acid41 topic

Where does Véronique Gelsi‐Boyer work?

Véronique Gelsi‐Boyer's main affiliation in the publication record is Institut Paoli-Calmettes, France.

How many publications and citations does Véronique Gelsi‐Boyer have?

OpenAlex counts 73 works and 5,550 citations for Véronique Gelsi‐Boyer, an h-index of 32, ranking #331,981 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Véronique Gelsi‐Boyer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.